CTU: Phase 1a/1b Study of BG-C9074, an Antibody Drug Conjugate Targeting B7H4, as Monotherapy and in Combination With Tislelizumab in Participants With Advanced Solid Tumors

  • Parsonson, Andrew (Primary Chief Investigator)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Martin, Lewis (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleBG-C9074-101
AcronymBG-C9074-101
StatusActive
Effective start/end date25/04/24 → 17/04/29